Litigation

Recent Posts

Novartis To Pay $422.5M For Off-Label Promotion Of 6 Drugs
Posted on 1 Oct 2010 by Tom Moylan

PHILADELPHIA -- Novartis Pharmaceuticals Corp. will pay $422.5 million in criminal and civil penalties to resolve off-label marketing allegations for six drugs, the federal government announced Sept. 30 ( United States of America v. Novartis Pharmaceuticals... Read More